Acid neutralization and bile acid binding capacity of hydrotalcite compared with other antacids: An in vitro study

Chinese Journal of Digestive Diseases

Volumn 4, Issue 3, 2003, Pages 140-146

  Miederer, Siegfried Ernst ^a   Wirtz, M ^b   Fladung, B ^c  

^a BIELEFELD UNIVERSITY   (Germany)

^b Bayer Health Care   (Germany)

^c BAYER PHARMA AG   (Germany)

Author keywords

Acid neutralization capacity; Bile acid binding; Duration of antacid action; Hydrotalcite; In vitro comparison

Indexed keywords

ALUMINUM HYDROXIDE; ALUMINUM MAGNESIUM HYDROXIDE; ALUMINUM MAGNESIUM SODIUM SILICATE; ANTACID AGENT; ATTAPULGITE; BELLADONNA ALKALOID; BICARBONATE; BILE ACID; CALCIUM CARBONATE; DIHYDROXYALUMINUM SODIUM CARBONATE; FAMOTIDINE; HYDROTALCITE; MAGALDRATE; MAGNESIUM CARBONATE; MAGNESIUM HYDROXIDE; METHIONINE DERIVATIVE; RENNIE; SIDASHU; TAURODEOXYCHOLIC ACID;

ARTICLE; BILE REFLUX; CHINA; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG BINDING; DRUG DETERMINATION; DRUG EFFICACY; GASTRITIS; GASTROESOPHAGEAL REFLUX; GERMANY; HEARTBURN; IN VITRO STUDY; MUCOSA INFLAMMATION; PRIORITY JOURNAL; STOMACH PH; TABLET FORMULATION;

EID: 0345327834     PISSN: 14439611     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1443-9573.2003.00132.x     Document Type: Article

References (16)

1. Konturek SJ, Brzozowski T, Marks IN, Miederer S, Peskar BM. Antacids and mucosal protection. Eur J Gastroenterol Hepatol 1992; 4: 954-65.
2. Brackmann HP. Physiological action principles in ulcer therapy. Therapiewoche 1985; 35: 4007-23.
3. Kovar KA, ed. Pharmazeutische Praxis, 6th edn. Stuttgart: Wissenschaftliche Verlagsgesellschaft, 2001.
4. Holtermuller KH, Liszkay M, Bernard I, Haase W. Therapy of stomach ulcer: a comparison between the low dosage antacid hydrotalcite and ranitidine: results of a randomized multicenter double-blind study ( Talcivent Study Group Z). Gastroenterology 1992; 30: 717-21.
5. Llewellyn AF, Tomkin CH, Murphy GM. The binding of bile acids by hydrotalcite and other antacid preparations. Pharm Acta Helv 1977; 52: 1-5.
6. Reimann HJ, Schmidt U, Bluemel G, Liszkay M. Mucosa protecting effect of Hydrotalcite against aspirin-induced lesions in men. Dig Dis Sci 1986; 31(Suppl. 10): 202S.
7. Playle AC, Gunning SR, Llewellyn AF. The in vitro antacid and anti-pepsin activity of hydrotalcite. Pharm Acta Helv 1974; 49: 298-302.
8. Tarnawski AS, Wang H, Tomikawa M, Pai R, Sarfeh IJ. Talcid triggers induction of heat shock proteins HSP-70 in gastric mucosa: a key to its mucosal protective action? Gastroenterology 1999; 116: A331.
9. Nehra D, Howell P, Pye JK, Beynon J. Assessment of combined bile acid and pH profiles using an automated sampling device in gastro-oesophageal reflux disease. Br J Surg 1998; 85: 134-7.
10. Ali SL. Comparative in vitro investigation of antacids. Pharm Zeit 1982; 127: 1482-9.
11. Xu CM, Li ZS, Zou DW et al. Effect of hydrotalcid on bile reflux gastritis and 24-hour intragastric bile. Chin J Intern Med 1998; 37: 598.
12. Prieto R, Martinez-Tobed A, Fabregas JL, Beneyto JE. In vitro comparison of the antacid potencies of almagate in tablets and suspension with those of other commercially available antacid preparations. Arzneimittelforschung 1984; 34: 1360-4.
13. Vatier JL, Gao Z, Fu-Cheng XM et al. Evidence for the interaction between antacid and gastric mucosa using an 'artificial stomach' model including gastric mucosa. J Pharmacol Exp Ther 1992; 263: 1206-11.
14. Metza K, R esch W. Comparison of commercially-available antacids. Z Gastroenterol 1981; 19: 212-21.
15. Mendelsohn D, Mendelsohn L. Hydrogen ion, pepsin and bile acid binding properties of hydrotalcite. S Afr Med J 1975; 49: 1011-14.
16. Hnsel W, Herzog T. Antacids in gallic acid reflux: In vitro study on the binding of gallic acids by calcium and magnesium ions. Deutsche Apotheker Zeit 1998; 138: 2536-9.